Table 1.
Demographics and risk factor characteristics of sample, classified by HTN status at midlife
| Total Sample (n = 378) |
Presence of Stage I HTN (n = 97) |
Absence of Stage I HTN (n = 251) |
|
|---|---|---|---|
| Age at NP Battery, years (Mean ± SD) | 86 ± 4 | 86 ± 4 | 86 ± 4 |
| Age at CV Risk Assessment, years (Mean ± SD) | 55 ± 1 | 55 ± 0.7 | 55 ± 0.8 |
| Time between CV Risk Assessment and NP Battery, years (Mean ± SD) | 31 ± 4 | 30.6 ± 4.3 | 30.5 ± 4.2 |
| Female, n (%) | 246 (65) | 63 (65) | 162 (65) |
| WRAT, Median [Q1, Q3] | 48 [43, 51] | 46 [42, 50] | 48 [43, 51] |
| Education group, n (%) | |||
| <HS Degree | 92 (24) | 23 (24) | 59 (24) |
| HS Degree | 157 (42) | 47 (48) | 94 (38) |
| Some College | 71 (19) | 17 (18) | 53 (21) |
| College Graduate | 57 (15) | 10 (10) | 44 (17) |
| Measures at Midlife | |||
| Systolic Blood Pressure, mmHg (Mean ± SD) | 127 ± 16 | 148 ± 12 | 120 ± 10 |
| ApoE4 Carriers, n (%) | 75 (20) | 14 (15) | 55 (22) |
| Current Smoking, n (%) | 98 (29) | 25 (28) | 78 (30) |
| Diabetes Mellitus, n (%) | 0 | 0 | 0 |
| Atrial Fibrillation, n (%) | 0 | 0 | 0 |
| Hypertension, n (%) | 97 (28) | 97 (100) | 251 (0) |
| Prevalent CVD, n (%) | 16 (4) | 3 (3) | 11 (4) |
| Measures at NP Assessment | |||
| Systolic Blood Pressure, mmHg (Mean ± SD) | 136 ± 21 | ||
| ApoE4 Carriers, n (%) | 75 (20) | ||
| Current Smoking, n (%) | 13 (3) | ||
| Diabetes Mellitus, n (%) | 50 (13) | ||
| Atrial Fibrillation, n (%) | 94 (25) | ||
| Hypertension, n (%) | 265 (70) | ||
| Prevalent CVD, n (%) | 190 (50) |
HTN, hypertension; NP, neuropsychological; SD, standard deviation; CV, cardiovascular; WRAT-III, Wide Range Achievement Test; HS, high school; ApoE4, apolipoprotein ε4; CVD, cardiovascular disease.